Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 103

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Bioreducible heparin-based nanogel drug delivery system

Wu, Wei, Yao, Wei, Wang, Xin, Xie, Chen, Zhang, Jialiang, Jiang, Xiqun · 2015 · Biomaterials

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2014.11.005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 25

  1. Chacko, 2012, Polymer nanogels: a versatile nanoscopic drug delivery platform, Adv Drug Delivery Rev, 64, 836, 10.1016/j.addr.2012.02.002 · DOI · Paper page
  2. Fleige, 2012, Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications, Adv Drug Delivery Rev, 64, 866, 10.1016/j.addr.2012.01.020 · DOI · Paper page
  3. Lee, 2004, Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by HEP and chitosan, Transpl Proc, 36, 2464, 10.1016/j.transproceed.2004.08.078 · DOI
  4. Borsig, 2002, Synergistic effects of l- and p-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis, Proc Natl Acad Sci U S A, 99, 2193, 10.1073/pnas.261704098 · DOI · Paper page
  5. Varki, 2002, HEP inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans, Semin Thromb Hemost, 28, 53, 10.1055/s-2002-20564 · DOI · Paper page
  6. Freeman, 1999, Evidence that platelet and tumour heparanases are similar enzymes, Biochem J, 342, 361, 10.1042/bj3420361 · doi:10.1042/bj3420361
  7. Wang, 2011, A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model, ACS Nano, 5, 6184, 10.1021/nn200739q · DOI
  8. Park, 2004, Preparation and characterization of self-assembled nanoparticles of HEP-deoxycholic acid conjugates, Langmuir, 20, 11726, 10.1021/la048646i · DOI
  9. Park, 2006, HEP-DOCA acid chemical conjugate as an anti-cancer drug carrier and its anti-tumor activity, J Control Release, 114, 300, 10.1016/j.jconrel.2006.05.017 · DOI · Paper page
  10. Park, 2008, Combination therapy of HEP-deoxycholic acid conjugate and doxorubicin against squamous cell carcinoma and B16F10 melanoma, Pharm Res, 25, 268, 10.1007/s11095-007-9366-5 · DOI
  11. Hou, 2012, Pharmacokinetics of a paclitaxel-loaded low molecular weight HEP-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system, Biomaterials, 33, 5431, 10.1016/j.biomaterials.2012.03.070 · DOI · Paper page
  12. Park, 2008, Tumor endothelial cell targeted cyclic RGD-modified HEP derivative: inhibition of angiogenesis and tumor growth, Pharm Res, 25, 2786, 10.1007/s11095-008-9643-y · DOI
  13. Wang, 2009, HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors, ACS Nano, 3, 3165, 10.1021/nn900649v · DOI · Paper page
  14. Bae, 2008, Synthesis, characterization, and intracellular delivery of reducible HEP nanogels for apoptotic cell death, Biomaterials, 29, 3376, 10.1016/j.biomaterials.2008.04.035 · DOI
  15. Raina, 1997, Making and breaking disulfide bonds, Annu Rev Microbiol, 51, 179, 10.1146/annurev.micro.51.1.179 · DOI · Paper page
  16. Kuppusamy, 2002, Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels, Cancer Res, 62, 307
  17. Sun, 2010, Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin, Biomaterials, 31, 7124, 10.1016/j.biomaterials.2010.06.011 · DOI · Paper page
  18. Kim, 2009, In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer, Mol Pharm, 6, 1353, 10.1021/mp900021q · DOI · Paper page
  19. Rytting, 2010, In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles, J Control Rel, 141, 101, 10.1016/j.jconrel.2009.08.021 · DOI
  20. Qian, 2014, Delivery of doxorubicin in vitro and in vivo using bio-reductive cellulose nanogels, Biomater Sci, 2, 220, 10.1039/C3BM60176E · DOI
  21. Cheng, 2012, Alginic acid nanoparticles prepared through counterion complexation method as a drug delivery system, ACS Appl Mater Interfaces, 4, 5325, 10.1021/am3012627 · DOI
  22. Bae, 2008, Synthesis, characterization, and intracellular delivery of reducible HEP nanogels for apoptotic cell death, Biomaterials, 29, 3376, 10.1016/j.biomaterials.2008.04.035 · DOI
  23. Saito, 2003, Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities, Adv Drug Delivery Rev, 55, 199, 10.1016/S0169-409X(02)00179-5 · DOI · Paper page
  24. Gupte, 2009, Elevated copper and oxidative stress in cancer cells as a target for cancer treatment, Cancer Treat Rev, 35, 32, 10.1016/j.ctrv.2008.07.004 · DOI · Paper page
  25. Cheng, 2012, In vitro and in vivo antitumor activity of doxorubicin-loaded aliginic-acid-based nanoparticles, Macromol Biosci, 12, 1326, 10.1002/mabi.201200165 · DOI

Cited by

See all 103

Metadata

Authors
Wu, W., Yao, W., Wang, X., Xie, C., Zhang, J., & Jiang, X.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2015-01
Volume
39
Pages
260-268
ISSN
0142-9612
Cited by
103
References
1
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Natural Science Foundation of China (51033002, 51273090)
  • Program for Changjiang Scholars and Innovative Research Team in University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioreducible heparin-based nanogel drug delivery system. https://app.cochat.ai/papers/10.1016/j.biomaterials.2014.11.005
The paper
Wu, W., Yao, W., Wang, X., Xie, C., Zhang, J., & Jiang, X. (2015). Bioreducible heparin-based nanogel drug delivery system. Biomaterials. https://doi.org/10.1016/j.biomaterials.2014.11.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.